AI Article Synopsis
- A 64-year-old woman with hypothyroidism and parotid sarcoidosis experienced sudden chest pain and shortness of breath.
- An echocardiogram showed a temporary drop in heart function, indicating stress-induced cardiomyopathy, with no blockage found in her coronary arteries.
- The patient's recent ketamine infusion for mental health issues might have triggered her cardiac symptoms, highlighting the need for caution when using ketamine in patients with heart conditions and the necessity for more research on its cardiovascular effects.
Article Abstract
We report the case of a 64-year-old female with a history of hypothyroidism and isolated parotid sarcoidosis who presented with acute-onset chest pain and dyspnea. Echocardiogram demonstrated transiently reduced ejection fraction with apical hypokinesis, without evidence of obstructive coronary lesions on angiography, compatible with stress-induced cardiomyopathy. She received a ketamine infusion as a mental health treatment shortly before the development of symptoms, suggesting that this medication may have precipitated her cardiomyopathy. In recent years, ketamine has become a popular option for treating mental health disorders, including major depressive disorder and substance use disorders. It should be used with caution in patients with known cardiovascular disease, and its cardiac effects warrant further study.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11152355 | PMC |
| http://dx.doi.org/10.7759/cureus.59709 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!